Speaking with investors and reporters, officials from Zimmer Holdings, Boston Scientific and Advanced Medical Technology Association, the industry trade group, said they opposed the proposal, which has not yet been written into legislation.
Ray Elliott, president and CEO of Boston Scientific, warned that the fees could lead to job cuts, reduced research and development, and moving company registrations offshore.
Read CNN Money’s report on proposed medical device company fees.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
